Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 122

1.

Mequindox Induced Genotoxicity and Carcinogenicity in Mice.

Liu Q, Lei Z, Wu Q, Huang D, Xie S, Wang X, Pan Y, Yuan Z.

Front Pharmacol. 2018 Apr 10;9:361. doi: 10.3389/fphar.2018.00361. eCollection 2018.

2.

Immunotoxic and hepatotoxic effects of perfluoro-n-decanoic acid (PFDA) on female Harlan Sprague-Dawley rats and B6C3F1/N mice when administered by oral gavage for 28 days.

Frawley RP, Smith M, Cesta MF, Hayes-Bouknight S, Blystone C, Kissling GE, Harris S, Germolec D.

J Immunotoxicol. 2018 Dec;15(1):41-52. doi: 10.1080/1547691X.2018.1445145.

PMID:
29514525
3.

Phase I study of tomuzotuximab, a glycoengineered therapeutic antibody against the epidermal growth factor receptor, in patients with advanced carcinomas.

Fiedler W, Cresta S, Schulze-Bergkamen H, De Dosso S, Weidmann J, Tessari A, Baumeister H, Danielczyk A, Dietrich B, Goletz S, Zurlo A, Salzberg M, Sessa C, Gianni L.

ESMO Open. 2018 Feb 1;3(2):e000303. doi: 10.1136/esmoopen-2017-000303. eCollection 2018.

4.

Treatment Related Hematologic Changes in a Population of Iranian Patients with Chronic Hepatitis C Infection from 2009 to 2014.

Ahmadinejad Z, Abdiliaei Z, Mohamadi R, Rezahosseini O.

Iran J Public Health. 2017 Oct;46(10):1386-1394.

5.

Evaluation of the Carcinogenic Potential of Roxadustat (FG-4592), a Small Molecule Inhibitor of Hypoxia-Inducible Factor Prolyl Hydroxylase in CD-1 Mice and Sprague Dawley Rats.

Beck J, Henschel C, Chou J, Lin A, Del Balzo U.

Int J Toxicol. 2017 Nov/Dec;36(6):427-439. doi: 10.1177/1091581817737232. Epub 2017 Nov 19.

PMID:
29153032
6.

Retinoic acid postconsolidation therapy for high-risk neuroblastoma patients treated with autologous haematopoietic stem cell transplantation.

Peinemann F, van Dalen EC, Enk H, Berthold F.

Cochrane Database Syst Rev. 2017 Aug 25;8:CD010685. doi: 10.1002/14651858.CD010685.pub3. Review.

PMID:
28840597
7.

Ten years of the Hunter Outcome Survey (HOS): insights, achievements, and lessons learned from a global patient registry.

Muenzer J, Jones SA, Tylki-Szymańska A, Harmatz P, Mendelsohn NJ, Guffon N, Giugliani R, Burton BK, Scarpa M, Beck M, Jangelind Y, Hernberg-Stahl E, Larsen MP, Pulles T, Whiteman DAH.

Orphanet J Rare Dis. 2017 May 2;12(1):82. doi: 10.1186/s13023-017-0635-z. Review.

8.

Evaluation of Quality of Life and Care Needs of Turkish Patients Undergoing Hematopoietic Stem Cell Transplantation.

Yasar N, Akin S.

Nurs Res Pract. 2016;2016:9604524. doi: 10.1155/2016/9604524. Epub 2016 Dec 26.

9.

Allogeneic Mesenchymal Precursor Cells (MPC) in Diabetic Nephropathy: A Randomized, Placebo-controlled, Dose Escalation Study.

Packham DK, Fraser IR, Kerr PG, Segal KR.

EBioMedicine. 2016 Oct;12:263-269. doi: 10.1016/j.ebiom.2016.09.011. Epub 2016 Sep 17.

10.

Progress in the diagnosis of and therapy for MDS.

Nannya Y.

Rinsho Ketsueki. 2016;57(10):1980-1990. Japanese.

PMID:
27725596
11.

Brain atrophy after bone marrow transplantation for treatment of multiple sclerosis.

Lee H, Narayanan S, Brown RA, Chen JT, Atkins HL, Freedman MS, Arnold DL.

Mult Scler. 2017 Mar;23(3):420-431. doi: 10.1177/1352458516650992. Epub 2016 Jul 11.

PMID:
27246142
12.

Evaluation of the utility of popliteal lymph node examination in a cyclophosphamide model of immunotoxicity in the rat.

Lapointe JM, Valdez RA, Ryan AM, Haley PJ.

J Immunotoxicol. 2016 Jul;13(4):449-52. doi: 10.3109/1547691X.2015.1122117. Epub 2016 May 23.

PMID:
27216540
13.

Changes in bone marrow morphology in adults receiving romiplostim for the treatment of thrombocytopenia associated with primary immune thrombocytopenia.

Janssens A, Rodeghiero F, Anderson D, Chong BH, Boda Z, Pabinger I, Červinek L, Terrell DR, Wang X, Franklin J.

Ann Hematol. 2016 Jun;95(7):1077-87. doi: 10.1007/s00277-016-2682-2. Epub 2016 Apr 30.

14.

Phase 1-2 pilot clinical trial in patients with decompensated liver cirrhosis treated with bone marrow-derived endothelial progenitor cells.

D'Avola D, Fernández-Ruiz V, Carmona-Torre F, Méndez M, Pérez-Calvo J, Prósper F, Andreu E, Herrero JI, Iñarrairaegui M, Fuertes C, Bilbao JI, Sangro B, Prieto J, Quiroga J.

Transl Res. 2017 Oct;188:80-91.e2. doi: 10.1016/j.trsl.2016.02.009. Epub 2016 Feb 24.

PMID:
26972567
15.

Post-Radiation Therapy Imaging Appearances in Cervical Carcinoma.

Papadopoulou I, Stewart V, Barwick TD, Park WH, Soneji N, Rockall AG, Bharwani N.

Radiographics. 2016 Mar-Apr;36(2):538-53. doi: 10.1148/rg.2016150117. Epub 2016 Feb 5. Review.

PMID:
26849153
16.

Improved Follow-Up and Response Monitoring of Thoracic Cage Involvement in Multiple Myeloma Using a Novel CT Postprocessing Software: The Lessons We Learned.

Bier G, Mustafa DF, Kloth C, Weisel K, Ditt H, Nikolaou K, Horger M.

AJR Am J Roentgenol. 2016 Jan;206(1):57-63. doi: 10.2214/AJR.15.15089.

PMID:
26700335
17.

Safety and tolerability of eltrombopag versus placebo for treatment of thrombocytopenia in patients with advanced myelodysplastic syndromes or acute myeloid leukaemia: a multicentre, randomised, placebo-controlled, double-blind, phase 1/2 trial.

Platzbecker U, Wong RS, Verma A, Abboud C, Araujo S, Chiou TJ, Feigert J, Yeh SP, Götze K, Gorin NC, Greenberg P, Kambhampati S, Kim YJ, Lee JH, Lyons R, Ruggeri M, Santini V, Cheng G, Jang JH, Chen CY, Johnson B, Bennett J, Mannino F, Kamel YM, Stone N, Dougherty S, Chan G, Giagounidis A.

Lancet Haematol. 2015 Oct;2(10):e417-26. doi: 10.1016/S2352-3026(15)00149-0. Epub 2015 Oct 1.

PMID:
26686043
18.

A prospective multi-site registry study of a specific protocol of autologous bone marrow concentrate for the treatment of shoulder rotator cuff tears and osteoarthritis.

Centeno CJ, Al-Sayegh H, Bashir J, Goodyear S, Freeman MD.

J Pain Res. 2015 Jun 5;8:269-76. doi: 10.2147/JPR.S80872. eCollection 2015.

19.

Irradiation and bone marrow reconstitution affect the functional Ly49 natural killer cell repertoire in rats.

Nestvold JM, Rolstad B.

Front Cell Dev Biol. 2015 May 27;3:34. doi: 10.3389/fcell.2015.00034. eCollection 2015.

20.

Development of hematological and immunological characteristics in neonatal rats.

Sewald K, Mueller M, Buschmann J, Hansen T, Lewin G.

Reprod Toxicol. 2015 Aug 15;56:109-17. doi: 10.1016/j.reprotox.2015.05.019. Epub 2015 Jun 6.

PMID:
26055945

Supplemental Content

Loading ...
Support Center